Track this case

Case Number:



Pennsylvania Eastern

Nature of Suit:

P.I.: Personal Inj. Prod. Liability

Multi Party Litigation:

Multi-district Litigation





Sectors & Industries:

  1. December 5, 2016

    Payor Swings Back At GSK Sanctions Bid In Avandia MDL

    Third-party payor United Benefit Fund told a Pennsylvania federal court on Friday that it should not be punished with sanctions for seeking to leave a class action alleging GlaxoSmithKline LLC misrepresented the safety of its Avandia diabetes drugs, pointing to evidence that its claims had merit and were not baseless.

  2. November 10, 2016

    GSK Seeks Sanctions Against Payors Quitting Avandia MDL

    GlaxoSmithKline LLC asked a Pennsylvania federal court on Wednesday to sanction two third-party payors that recently asked to drop their class actions against GSK over the safety of its Avandia diabetes drugs, saying they should be punished for pursuing claims for years without the evidence to back them up.

  3. August 26, 2016

    Third-Party Payors Say GSK Skews Avandia Claims

    Third-party payors in a class action alleging GlaxoSmithKline LLC misrepresented the safety of its Avandia diabetes drugs told a Pennsylvania federal judge on Thursday that the pharmaceutical company is distorting what they’re actually claiming.

  4. August 5, 2016

    GSK May See Payor Exit Diabetes Drug Suit On Own Accord

    United Benefit Fund, one of four payors who filed a class action alleging GlaxoSmithKline LLC misrepresented the safety of its Avandia diabetes drugs, took one for the team Friday and asked a Pennsylvania federal court to kill its own claims for a faster resolution.

  5. April 20, 2015

    GSK Dodges Avandia Side-Effect Disclosure Class Action

    A Pennsylvania federal judge has ruled that the lead plaintiff in a proposed class action rolled into multidistrict litigation covering claims that GlaxoSmithKline LLC concealed dangerous side effects of its diabetes drug Avandia failed to show that she was harmed in any way.

  6. July 1, 2014

    GSK Wants 3rd Circ. To Toss RICO Claims In Avandia MDL

    GlaxoSmithKline LLC on Monday asked the Third Circuit to toss racketeering claims in three class actions accusing the drugmaker of hiding heart disease risks associated with the diabetes drug Avandia, arguing the plaintiffs haven’t alleged a clearly identifiable injury.

  7. June 12, 2014

    Girardi Keese To Appeal GSK Avandia Fee Holdbacks

    Girardi Keese said Tuesday that it will appeal to the Third Circuit to fight a May order requiring GlaxoSmithKline to hold back 7 percent of the gross recovery from all Girardi cases in the sprawling Avandia product liability multidistrict litigation.

  8. May 16, 2014

    GlaxoSmithKline Gets 115 Avandia Injury Cases Dismissed

    A Pennsylvania district judge dismissed 115 out of 117 cases that GlaxoSmithKline LLC argued were outside the statute of limitations in the multidistrict litigation over injuries caused by diabetes drug Avandia, ruling Friday that the cases were clearly untimely.

  9. February 26, 2014

    GSK Can't Shake Calif. County's Avandia False Ad Claims

    A Pennsylvania federal judge on Tuesday denied GlaxoSmithKline PLC's bid to partially dismiss false advertising claims brought by Santa Clara County, Calif., over GSK's diabetes medication Avandia, rejecting its argument that the claims must be based on false advertising displayed within the county.

  10. October 24, 2013

    GSK Can't Sink Avandia Prescription Coverage RICO Suits

    GlaxoSmithKline LLC failed Wednesday to escape a trio of racketeering class actions in Pennsylvania federal court alleging its concealment of heart risks associated with the diabetes drug Avandia conned health benefit payors into covering pricey prescriptions.